Investigation of Continuous Versus Interrupted Subcutaneous Fat Closure in Reducing Surgical Site Infection

Launched by THE UNIVERSITY OF THE WEST INDIES · May 3, 2023

Keywords

ClinConnect Summary

This clinical trial is studying the best way to close the fatty tissue under the skin in overweight or obese women who are having a planned cesarean section. The goal is to see if one method of closure can help reduce the risk of infections at the surgery site, which can be a concern for many patients. The study will involve 266 participants and is being conducted at Victoria Jubilee Hospital over six months.

To be eligible for this study, women must be overweight or obese (with a body mass index greater than 25) and be expecting a single baby at 37 to 41 weeks of pregnancy. However, certain individuals, such as those with weakened immune systems, multiple pregnancies, or specific health conditions, will not be included. Participants will be followed up seven days after surgery, and their recovery will be checked through phone questionnaires at four weeks and three months post-surgery. This will help researchers gather information on how well the surgery went and if there were any issues.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Overweight/Obese Women \> 25kg/m2, measured in the first trimester
• • Single Fetus
• • Gestational Age (37-41) week calculated by sure dates and confirmed by first trimester ultrasound
• • Elective Lower Segment Cesarean Section
• Exclusion Criteria:
• • Patients who are immune-compromised e.g. Known Diabetes Mellitus or HIV positive mothers
• • Patients who are on long term Steroid use: e.g. SLE, Rheumatoid Arthritis
• • Multifetal Pregnancy
• • Those with anemia, requiring transfusion
• • Obstetric Complications: e.g. Placenta Previa
• • Any mother who wishes not to participate in the study